gefitinib has been researched along with Pyoderma Gangrenosum in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iijima, M; Kitami, A; Nakada, T; Sagara, R | 1 |
1 other study(ies) available for gefitinib and Pyoderma Gangrenosum
| Article | Year |
|---|---|
Adverse reactions to gefitinib (Iressa): revealing sycosis- and pyoderma gangrenosum-like lesions.
Topics: Antineoplastic Agents; Folliculitis; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Pyoderma Gangrenosum; Quinazolines | 2006 |